Latest Content

Spotlighting Pancreatic Cancer Disparities in Black Communities

June 23rd 2025, 4:14pm

By Ryan Scott

Article

Tripp Razor highlights the disproportionately high pancreatic cancer risk among Black Americans and the systemic disparities they face in access to care.

Illuccix is FDA Approved to Guide Radioligand Use in Prostate Cancer

June 23rd 2025, 3:00pm

By Spencer Feldman

Article

Illuccix is now FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

What Should Patients with Multiple Myeloma Know After ASCO 2025?

June 23rd 2025, 1:00pm

By Dr. Joshua K. Sabari

Video

Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies following the 2025 ASCO Meeting.

Improving Distant Control in Lung Cancer With JNJ-1900 and Keytruda

June 22nd 2025, 6:00pm

By Dr. Jared Weiss

Video

Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.

Experts Impart Notable Information and Updates for Those With Blood Cancers

June 22nd 2025, 2:00pm

By Dr. Joshua K. Sabari

Article

The 2025 ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple myeloma and lymphoma.

Breaking Down Clinical Trial Participation in Kidney Cancer: Is it Right for You?

June 21st 2025, 6:00pm

By Dr. Michael Serzan

Video

Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.

What Patients With Polycythemia Vera Should Know After ASCO 2025

June 21st 2025, 2:00pm

By Dr. Joshua K. Sabari

Article

Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about recent data from ASCO 2025.

Radiation and Resilience: Laughing Through the Hardest Days

June 20th 2025, 9:00pm

By Dave Davison

Article

It’s a bad day when a doctor says you have cancer. It’s a worse day when he says it’s stage prostate cancer with a metastatic lesion.

Clinical Trial Corner: New Treatments in Leukemia, Lymphoma and Brain Cancers

June 20th 2025, 7:00pm

By Spencer Feldman

Article

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing safety/activity with novel therapies.

The Path Forward: Thriving in Cancer Survivorship

June 20th 2025, 5:00pm

By Tamron Little

Article

Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those walking behind me.

Advancements Reshape Treatment for Non-Small Cell Lung Cancer

June 20th 2025, 4:00pm

By Ryan Scott

Article

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the REZILIENT-1 and NeoADAURA trials.

Personalized Therapy Helps Tailor Treatment for GIST

June 20th 2025, 3:00pm

By Dr. Breelyn Wilky

Video

Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.

Can ctDNA Help Guide Surgical Decision Making in Breast Cancer

June 20th 2025, 1:00pm

By Dr. Rita Mukhtar

Video

Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.

Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

June 19th 2025, 9:00pm

By Mindy Sue Cohen

Article

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.

Experts Walk Through Recent Hematologic Malignancy Treatment Updates

June 19th 2025, 8:00pm

By Ryan Scott

Video

Dr. Raajit K. Rampal and Dr. Joshua K. Sabari walk through updates for patients in the treatment of blood cancers, including polycythemia vera.